New Zealand markets close in 1 hour 48 minutes

Xilio Therapeutics, Inc. (XLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0800+0.0400 (+3.85%)
At close: 04:00PM EDT
1.0900 +0.01 (+0.93%)
After hours: 07:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 38.39M
Enterprise value 6.19M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.04
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.08

Trading information

Stock price history

Beta (5Y monthly) -0.08
52-week change 3-63.14%
S&P500 52-week change 323.57%
52-week high 33.2500
52-week low 30.4900
50-day moving average 30.9401
200-day moving average 31.5008

Share statistics

Avg vol (3-month) 31.25M
Avg vol (10-day) 3258.26k
Shares outstanding 536.91M
Implied shares outstanding 636.91M
Float 817.62M
% held by insiders 129.79%
% held by institutions 146.20%
Shares short (15 Apr 2024) 4379.49k
Short ratio (15 Apr 2024) 40.12
Short % of float (15 Apr 2024) 41.21%
Short % of shares outstanding (15 Apr 2024) 41.03%
Shares short (prior month 15 Mar 2024) 457.63k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-49.44%
Return on equity (ttm)-107.25%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -77.23M
Net income avi to common (ttm)-76.4M
Diluted EPS (ttm)-2.7800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)44.7M
Total cash per share (mrq)1.3
Total debt (mrq)12.55M
Total debt/equity (mrq)34.08%
Current ratio (mrq)3.02
Book value per share (mrq)1.33

Cash flow statement

Operating cash flow (ttm)-68.62M
Levered free cash flow (ttm)-42.32M